APA (7th ed.) Citation

JK, L., RA, S., KR, G., J, V., MA, T., AM, B., . . . ES, K. (2024). Hemodynamic Response to Oral Vasodilator Therapy in Systemic Sclerosis-Related Pulmonary Hypertension. Cardiovascular drugs and therapy, 38(3), 651. https://doi.org/10.1007/s10557-022-07420-1

Chicago Style (17th ed.) Citation

JK, Lui, et al. "Hemodynamic Response to Oral Vasodilator Therapy in Systemic Sclerosis-Related Pulmonary Hypertension." Cardiovascular Drugs and Therapy 38, no. 3 (2024): 651. https://doi.org/10.1007/s10557-022-07420-1.

MLA (9th ed.) Citation

JK, Lui, et al. "Hemodynamic Response to Oral Vasodilator Therapy in Systemic Sclerosis-Related Pulmonary Hypertension." Cardiovascular Drugs and Therapy, vol. 38, no. 3, 2024, p. 651, https://doi.org/10.1007/s10557-022-07420-1.